Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FVJT2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,179
Award facts
- Contract value 100% obligated
- $10,178.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication in 3 mL vials, with a ceiling value of $10,178.72. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with performance at the contractor's facility in Conshohocken, Pennsylvania, and an ultimate completion date of August 29, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The specific delivery order for Ozempic, a diabetes medication, represents one component of the contractor's extensive portfolio of pharmaceutical products provided through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FVJT2?
SPE2DB25FVJT2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FVJT2 worth?
The government has obligated $10,179 on SPE2DB25FVJT2.
Is contract SPE2DB25FVJT2 an order under another contract?
Yes. SPE2DB25FVJT2 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVJT2 competed?
The extent of competition for SPE2DB25FVJT2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award